Skip to content

德康医疗

US · DXCM #635 按市值排名 上市于 2005
86.04 -1.67 -1.90%
实时 - 追踪5344个代码 - 心跳于353秒前 · 2026-10-16 20:01

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了4家。
  • 机构持股总比例下降了0.2个百分点。

机构持股

机构持股比例
105.03% -0.17pp
机构数量
1,205 -4
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund85.36%
Public Company5.46%
Hedge Fund5.14%
Government Pension Fund3.17%
Private Company3.12%
Sovereign Wealth Fund2.00%
Insurance Company0.25%
Individual/Insider0.24%
VC/PE Fund0.21%

主要股东 截至 2026-06-30

BlackRock 10.13% · 38.24M 股
Vanguard Capital Management, LLC 7.27% · 27.43M 股
Vanguard Portfolio Management, LLC 5.21% · 19.66M 股
State Street Global Advisors 4.87% · 18.38M 股
UBS Asset Management 4.59% · 17.33M 股
Baillie Gifford 3.92% · 14.80M 股
Invesco Capital Management LLC 3.86% · 14.58M 股
Geode Capital Management, LLC 3.29% · 12.43M 股
AllianceBernstein 3.10% · 11.69M 股
Wellington Management Group 2.26% · 8.53M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 14次买入 · 35次卖出

姓名职务持股比例
Jacob Leach Chief Operating Officer 0.09%
Kevin Sayer Chairperson & CEO 0.05%
Steven Altman Independent Director 0.02%
Jereme Sylvain Chief Financial Officer 0.02%
Sadie Stern Executive Vice President 0.01%
Mark Foletta Lead Independent Director 0.01%
Richard Collins Independent Director 0.01%
Nicholas Augustinos Independent Director 0.01%
Michael Brown Chief Legal Officer 0.01%
Bridgette Heller Independent Director 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-27 Sadie Stern Executive Vice President Automatic Disposition -2,565 $86.15
2026-09-14 Nicholas Augustinos Independent Director Automatic Disposition -8,089 $84.02–84.04
2026-09-14 Nicholas Augustinos Independent Director Intent to Sell (Form 144) -6,539 $84.04
2026-09-14 Michael Brown Chief Legal Officer Automatic Disposition -1,700 $84.04
2026-09-13 Nicholas Augustinos Independent Director Intent to Sell (Form 144) -1,550 $84.02
2026-09-09 Glenn Boehnlein Independent Director Other Acquisition +5,841 --
2026-09-09 Glenn Boehnlein Independent Director Initial Statement of Beneficial 0 --
2026-09-09 Jereme Sylvain Chief Financial Officer Automatic Disposition -3,638 $83.27
2026-08-26 Sadie Stern Executive Vice President Automatic Disposition -2,565 $88.37
2026-08-21 Jacob Leach Chief Operating Officer Sale to Issuer -1,451 $92.34
2026-08-21 Jereme Sylvain Chief Financial Officer Sale to Issuer -1,451 $92.34
2026-08-21 Sadie Stern Executive Vice President Sale to Issuer -1,451 $92.34
2026-08-21 Michael Brown Chief Legal Officer Sale to Issuer -1,451 $92.34
2026-08-19 Kevin Sayer Chairperson & CEO Automatic Disposition -26,756 $89.71–91.41
2026-08-13 Michael Brown Chief Legal Officer Automatic Disposition -1,700 $91.93
2026-08-11 Nicholas Augustinos Independent Director Other Disposition -1,075 --
2026-08-11 Bridgette Heller Independent Director Automatic Disposition -1,012 $88.29
2026-08-02 Mark Foletta Lead Independent Director Intent to Sell (Form 144) -2,000 $85.32
2026-08-02 Mark Foletta Lead Independent Director Automatic Disposition -4,000 $80.00–85.32
2026-07-30 Mark Foletta Lead Independent Director Intent to Sell (Form 144) -2,000 $80.00

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:01:15 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

德康医疗 讨论区 0 条评论

发表评论